Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Invivo Therapeutics Holdings Corp. (NVIV) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Invivo Therapeutics Holdings Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1292519.
Total stock buying since 2014: $142,551.
Total stock sales since 2014: $64,947.
Total stock option exercises since 2014: $62,901.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 330,000 | $117,833 | 0 | $0 | 0 | $0 |
| 2020 | 10,908 | $0 | 0 | $0 | 0 | $0 |
| 2019 | 0 | $0 | 5,229 | $5,072 | 0 | $0 |
| 2017 | 0 | $0 | 0 | $0 | 89,387 | $25,921 |
| 2016 | 0 | $0 | 0 | $0 | 105,000 | $30,450 |
| 2015 | 2,000 | $24,718 | 0 | $0 | 20,000 | $5,800 |
| 2014 | 0 | $0 | 50,000 | $59,875 | 10,000 | $730 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-02 | 330,000 | $117,833 | 0 | $0 | 0 | $0 |
| 2020-03 | 10,908 | $0 | 0 | $0 | 0 | $0 |
| 2019-06 | 0 | $0 | 5,229 | $5,072 | 0 | $0 |
| 2017-04 | 0 | $0 | 0 | $0 | 30,984 | $8,985 |
| 2017-02 | 0 | $0 | 0 | $0 | 58,403 | $16,936 |
| 2016-08 | 0 | $0 | 0 | $0 | 70,000 | $20,300 |
| 2016-02 | 0 | $0 | 0 | $0 | 35,000 | $10,150 |
| 2015-12 | 0 | $0 | 0 | $0 | 20,000 | $5,800 |
| 2015-08 | 2,000 | $24,718 | 0 | $0 | 0 | $0 |
| 2014-08 | 0 | $0 | 0 | $0 | 10,000 | $730 |
| 2014-05 | 0 | $0 | 50,000 | $59,875 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-06 | Foose Brice (10% Owner) | Buy | 164,000 | .43 | 70,192 |
| 2023-02-05 | Foose Brice (10% Owner) | Buy | 166,000 | .29 | 47,641 |
| 2020-03-10 | Toselli Richard M. (See Remarks) | Buy | 3,636 | .00 | 0 |
| 2020-03-10 | Christopher Richard (CFO and Treasurer) | Buy | 3,636 | .00 | 0 |
| 2020-03-10 | Merrifield C Ann | Buy | 3,636 | .00 | 0 |
| 2019-06-04 | Toselli Richard M. (See Remarks) | Sale | 5,229 | .97 | 5,072 |
| 2017-04-13 | Roberts Richard John | Option Ex | 30,984 | .29 | 8,985 |
| 2017-02-16 | Roberts Richard John | Option Ex | 58,403 | .29 | 16,936 |
| 2016-08-19 | Roberts Richard John (Director) | Option Ex | 70,000 | .29 | 20,300 |
| 2016-02-10 | Roberts Richard John | Option Ex | 35,000 | .29 | 10,150 |
| 2015-12-29 | Roberts Richard John | Option Ex | 20,000 | .29 | 5,800 |
| 2015-08-12 | Merrifield C Ann | Buy | 2,000 | 12.36 | 24,718 |
| 2014-08-08 | Roberts Richard John | Option Ex | 10,000 | .07 | 730 |
| 2014-05-09 | Reynolds Francis (10% Owner) | Sale | 12,500 | 1.20 | 15,000 |
| 2014-05-08 | Reynolds Francis (10% Owner) | Sale | 12,500 | 1.19 | 14,875 |
| 2014-05-07 | Reynolds Francis (10% Owner) | Sale | 25,000 | 1.20 | 30,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVIV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Invivo Therapeutics Holdings Corp. (symbol NVIV, CIK number 1292519) see the Securities and Exchange Commission (SEC) website.